Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy

NCT: NCT02199015 · NOT_YET_RECRUITING

NCT IDNCT02199015
StatusNOT_YET_RECRUITING
Start Date2027-06-01
Completion2030-12-31

Brief Summary

The aim of our work is to investigate whether electrical Lateral Cord Stimulation (LCS) causes an inhibitory and modulatory action by indirect cerebellar activation, so releasing spasticity and the spastic syndrome in selected cases of patients with cerebral palsy

Frequently Asked Questions

What is Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy?

Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy is a clinical trial registered under NCT02199015. Current status: NOT_YET_RECRUITING.

What is the status of NCT02199015?

The current status of NCT02199015 (Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy) is: NOT_YET_RECRUITING.

When did Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy start?

Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy started on 2027-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑